245 related articles for article (PubMed ID: 29941831)
1. Ubidecarenone-Loaded Nanostructured Lipid Carrier (UB-NLC): Percutaneous Penetration and Protective Effects Against Hydrogen Peroxide-Induced Oxidative Stress on HaCaT Cells.
Wang J; Wang H; Xia Q
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29941831
[TBL] [Abstract][Full Text] [Related]
2. The advantages of a novel CoQ10 delivery system in skin photo-protection.
Yue Y; Zhou H; Liu G; Li Y; Yan Z; Duan M
Int J Pharm; 2010 Jun; 392(1-2):57-63. PubMed ID: 20302925
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions.
Brugè F; Damiani E; Puglia C; Offerta A; Armeni T; Littarru GP; Tiano L
Int J Pharm; 2013 Oct; 455(1-2):348-56. PubMed ID: 23850626
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of nanostructured lipid carrier of ubiquinone (Coenzyme Q10).
Nanjwade BK; Kadam VT; Manvi FV
J Biomed Nanotechnol; 2013 Mar; 9(3):450-60. PubMed ID: 23621001
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro.
Wang J; Xia Q
Drug Deliv; 2014 Aug; 21(5):328-41. PubMed ID: 24144220
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique.
Chen S; Liu W; Wan J; Cheng X; Gu C; Zhou H; Chen S; Zhao X; Tang Y; Yang X
Drug Dev Ind Pharm; 2013 Jan; 39(1):20-8. PubMed ID: 23116283
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone.
Li B; Ge ZQ
AAPS PharmSciTech; 2012 Mar; 13(1):276-83. PubMed ID: 22234598
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation.
Khurana S; Jain NK; Bedi PM
Drug Dev Ind Pharm; 2015; 41(8):1368-75. PubMed ID: 25151872
[TBL] [Abstract][Full Text] [Related]
10. Ultra-small NLC for improved dermal delivery of coenyzme Q10.
Schwarz JC; Baisaeng N; Hoppel M; Löw M; Keck CM; Valenta C
Int J Pharm; 2013 Apr; 447(1-2):213-7. PubMed ID: 23438979
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.
Savić V; Ilić T; Nikolić I; Marković B; Čalija B; Cekić N; Savić S
Int J Pharm; 2019 Oct; 569():118624. PubMed ID: 31419461
[TBL] [Abstract][Full Text] [Related]
13. A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations.
Muheem A; Shakeel F; Warsi MH; Jain GK; Ahmad FJ
J Pharm Sci; 2017 Oct; 106(10):3050-3065. PubMed ID: 28552692
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
Okonogi S; Riangjanapatee P
Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity.
Puglia C; Lauro MR; Offerta A; Crascì L; Micicchè L; Panico AM; Bonina F; Puglisi G
Planta Med; 2017 Mar; 83(5):398-404. PubMed ID: 27124246
[TBL] [Abstract][Full Text] [Related]
16. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
18. Ultra-small lipid nanoparticles promote the penetration of coenzyme Q10 in skin cells and counteract oxidative stress.
Lohan SB; Bauersachs S; Ahlberg S; Baisaeng N; Keck CM; Müller RH; Witte E; Wolk K; Hackbarth S; Röder B; Lademann J; Meinke MC
Eur J Pharm Biopharm; 2015 Jan; 89():201-7. PubMed ID: 25500282
[TBL] [Abstract][Full Text] [Related]
19. A comparative study on the possible cytotoxic effects of different nanostructured lipid carrier (NLC) compositions in human dermal fibroblasts.
Brugè F; Damiani E; Marcheggiani F; Offerta A; Puglia C; Tiano L
Int J Pharm; 2015 Nov; 495(2):879-85. PubMed ID: 26392245
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
